Novo Nordisk A/S: Ryzodeg(R) (insulin degludec/insulin aspart)
Novo Nordisk A/S: Ryzodeg(R) (insulin degludec/insulin aspart) approved in Japan
BAGSVAERD DENMARK -- (Marketwire) -- 12/25/12 -- Company announcement No 84 / 2012: http://hugin.info/2013/R/1667087/541141.pdf
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Thomson Reuters ONE [HUG#1667087]
Novo Nordisk T. Tlf. +45 44 44 88 88 F. Fax +45 44 44 49 05